|
|
||||||||
Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan
The expression of MD-2, which associates with Toll-like receptor (TLR) 4 on the cell surface, confers LPS and LPS-mimetic Taxol responsiveness on TLR4. Alanine-scanning mutagenesis was performed to identify the mouse MD-2 residues important for conferring LPS and Taxol responsiveness on mouse TLR4, and for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 Ab MTS510. Single alanine mutations were introduced into mouse MD-2 (residues 17160), and the mutants were expressed in a human cell line expressing mouse TLR4. Mouse MD-2 mutants, in which a single alanine mutation was introduced at Cys37, Leu71, Leu78, Cys95, Tyr102, Cys105, Glu111, Val113, Ile117, Pro118, Phe119, Glu136, Ile138, Leu146, Cys148, or Thr152, showed dramatically reduced ability to form the cell surface mouse TLR4-mouse MD-2 complex recognized by MTS510, and the mutants also showed reduced ability to confer LPS and Taxol responsiveness. In contrast, mouse MD-2 mutants, in which a single alanine mutation was introduced at Tyr34, Tyr36, Gly59, Val82, Ile85, Phe126, Pro127, Gly129, Ile153, Ile154, and His155 showed normal ability to form the cell surface mouse TLR4-mouse MD-2 complex recognized by MTS510, but their ability to confer LPS and Taxol responsiveness was apparently reduced. These results suggest that the ability of MD-2 to form the cell surface mouse TLR4-mouse MD-2 complex recognized by MTS510 is essential for conferring LPS and Taxol responsiveness on TLR4, but not sufficient. In addition, the required residues at codon numbers 34, 85, 101, 122, and 153 for the ability of mouse MD-2 to confer LPS responsiveness are partly different from those for Taxol responsiveness.
This article has been cited by other articles:
![]() |
J. Vasl, P. Prohinar, T. L. Gioannini, J. P. Weiss, and R. Jerala Functional Activity of MD-2 Polymorphic Variant Is Significantly Different in Soluble and TLR4-Bound Forms: Decreased Endotoxin Binding by G56R MD-2 and Its Rescue by TLR4 Ectodomain J. Immunol., May 1, 2008; 180(9): 6107 - 6115. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Teghanemt, F. Re, P. Prohinar, R. Widstrom, T. L. Gioannini, and J. P. Weiss Novel Roles in Human MD-2 of Phenylalanines 121 and 126 and Tyrosine 131 in Activation of Toll-like Receptor 4 by Endotoxin J. Biol. Chem., January 18, 2008; 283(3): 1257 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gradisar, M. M. Keber, P. Pristovsek, and R. Jerala MD-2 as the target of curcumin in the inhibition of response to LPS J. Leukoc. Biol., October 1, 2007; 82(4): 968 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobayashi, S.-i. Saitoh, N. Tanimura, K. Takahashi, K. Kawasaki, M. Nishijima, Y. Fujimoto, K. Fukase, S. Akashi-Takamura, and K. Miyake Regulatory Roles for MD-2 and TLR4 in Ligand-Induced Receptor Clustering J. Immunol., May 15, 2006; 176(10): 6211 - 6218. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Viriyakosol, P. S. Tobias, and T. N. Kirkland Mutational Analysis of Membrane and Soluble Forms of Human MD-2 J. Biol. Chem., April 28, 2006; 281(17): 11955 - 11964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muroi and K.-i. Tanamoto Structural Regions of MD-2 That Determine the Agonist-Antagonist Activity of Lipid IVa J. Biol. Chem., March 3, 2006; 281(9): 5484 - 5491. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Covert, T. H. Leung, J. E. Gaston, and D. Baltimore Achieving Stability of Lipopolysaccharide-Induced NF-{kappa}B Activation Science, September 16, 2005; 309(5742): 1854 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bulut, K. S. Michelsen, L. Hayrapetian, Y. Naiki, R. Spallek, M. Singh, and M. Arditi Mycobacterium Tuberculosis Heat Shock Proteins Use Diverse Toll-like Receptor Pathways to Activate Pro-inflammatory Signals J. Biol. Chem., June 3, 2005; 280(22): 20961 - 20967. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mancek Keber, H. Gradisar, and R. Jerala MD-2 and Der p 2 -- a tale of two cousins or distant relatives? Innate Immunity, June 1, 2005; 11(3): 186 - 192. [Abstract] [PDF] |
||||
![]() |
S. Ichikawa, T. Takai, T. Inoue, T. Yuuki, Y. Okumura, K. Ogura, F. Inagaki, and H. Hatanaka NMR Study on the Major Mite Allergen Der f 2: Its Refined Tertiary Structure, Epitopes for Monoclonal Antibodies and Characteristics Shared by ML Protein Group Members J. Biochem., March 1, 2005; 137(3): 255 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gruber, M. Mancek, H. Wagner, C. J. Kirschning, and R. Jerala Structural Model of MD-2 and Functional Role of Its Basic Amino Acid Clusters Involved in Cellular Lipopolysaccharide Recognition J. Biol. Chem., July 2, 2004; 279(27): 28475 - 28482. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Gioannini, A. Teghanemt, D. Zhang, N. P. Coussens, W. Dockstader, S. Ramaswamy, and J. P. Weiss Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations PNAS, March 23, 2004; 101(12): 4186 - 4191. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Caivano, C. Rodriguez, P. Cohen, and S. Alemany 15-Deoxy-{Delta}12,14-prostaglandin J2 Regulates Endogenous Cot MAPK Kinase Kinase 1 Activity Induced by Lipopolysaccharide J. Biol. Chem., December 26, 2003; 278(52): 52124 - 52130. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Visintin, E. Latz, B. G. Monks, T. Espevik, and D. T. Golenbock Lysines 128 and 132 Enable Lipopolysaccharide Binding to MD-2, Leading to Toll-like Receptor-4 Aggregation and Signal Transduction J. Biol. Chem., November 28, 2003; 278(48): 48313 - 48320. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Re and J. L. Strominger Separate Functional Domains of Human MD-2 Mediate Toll-Like Receptor 4-Binding and Lipopolysaccharide Responsiveness J. Immunol., November 15, 2003; 171(10): 5272 - 5276. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sabroe, R. C. Read, M. K. B. Whyte, D. H. Dockrell, S. N. Vogel, and S. K. Dower Toll-Like Receptors in Health and Disease: Complex Questions Remain J. Immunol., August 15, 2003; 171(4): 1630 - 1635. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |